Management of axitinib (AG-013736)-induced fatigue and thyroid dysfunction, and predictive biomarkers of axitinib exposure: results from phase I studies in Japanese patients
2011 · Investigational New Drugs · 61 citations
https://doi.org/10.1007/s10637-011-9637-1